Mark E. Dmytruk Ginkgo Bioworks Holdings, Inc. (DNA) insider trading activity

Mark E. Dmytruk is Officer of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 31,610 shares of DNA, which is worth approximately $208,309. The most recent transaction as insider was on Nov 04, 2024, when has been sold 1,322 shares (Class A Common Stock) at a price of $7.58 per share, resulting in proceeds of $10,020. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.6K

97.1% 3M change

95.02% 12M change

Total Value Held $208,309

Mark E. Dmytruk Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 04 2024	SELL Open market or private sale	$10,020 $7.58 p/Share	1,322 Reduced 4.01%	31,610 Class A Common Stock
Nov 01 2024	BUY Exercise of conversion of derivative security	-	2,695 Added 7.56%	32,932 Class A Common Stock
Oct 04 2024	SELL Open market or private sale	$10,161 $8.35 p/Share	1,217 Reduced 3.87%	30,237 Class A Common Stock
Oct 03 2024	BUY Exercise of conversion of derivative security	-	2,705 Added 7.92%	31,454 Class A Common Stock
Sep 12 2024	SELL Open market or private sale	$7,083 $6.17 p/Share	1,148 Reduced 3.84%	28,749 Class A Common Stock
Sep 11 2024	BUY Exercise of conversion of derivative security	-	2,693 Added 8.26%	29,897 Class A Common Stock
Aug 02 2024	SELL Open market or private sale	$18,434 $0.29 p/Share	63,567 Reduced 5.52%	1,088,186 Class A Common Stock
Aug 01 2024	BUY Exercise of conversion of derivative security	-	108,127 Added 8.58%	1,151,753 Class A Common Stock
Jul 02 2024	SELL Open market or private sale	$16,223 $0.33 p/Share	49,162 Reduced 4.5%	1,043,626 Class A Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	-	108,126 Added 9.0%	1,092,788 Class A Common Stock
Jun 03 2024	SELL Open market or private sale	$26,876 $0.55 p/Share	48,866 Reduced 4.73%	984,662 Class A Common Stock
May 31 2024	BUY Exercise of conversion of derivative security	-	108,128 Added 9.47%	1,033,528 Class A Common Stock
May 02 2024	SELL Open market or private sale	$40,157 $0.84 p/Share	47,806 Reduced 4.91%	925,400 Class A Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	-	108,127 Added 10.0%	973,206 Class A Common Stock
Apr 02 2024	SELL Open market or private sale	$53,727 $1.05 p/Share	51,169 Reduced 5.58%	865,079 Class A Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	-	108,123 Added 10.56%	916,248 Class A Common Stock
Mar 04 2024	SELL Open market or private sale	$48,920 $1.26 p/Share	38,826 Reduced 4.58%	808,125 Class A Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	-	85,214 Added 9.14%	846,951 Class A Common Stock
Feb 02 2024	SELL Open market or private sale	$47,878 $1.21 p/Share	39,569 Reduced 4.94%	761,737 Class A Common Stock
Feb 01 2024	BUY Exercise of conversion of derivative security	-	85,208 Added 9.61%	801,306 Class A Common Stock
Jan 03 2024	SELL Open market or private sale	$70,522 $1.54 p/Share	45,794 Reduced 6.01%	716,098 Class A Common Stock
Jan 02 2024	BUY Exercise of conversion of derivative security	-	85,048 Added 10.04%	761,892 Class A Common Stock
Dec 04 2023	SELL Open market or private sale	$58,938 $1.39 p/Share	42,402 Reduced 5.9%	676,844 Class A Common Stock
Dec 01 2023	BUY Exercise of conversion of derivative security	-	85,040 Added 10.57%	719,246 Class A Common Stock
Nov 02 2023	SELL Open market or private sale	$55,843 $1.5 p/Share	37,229 Reduced 5.54%	634,206 Class A Common Stock

MED

Mark E. Dmytruk

Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Value

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Track Activities on DNA

Account